INTRODUCTION: Dementia is a multifactorial disease with Alzheimer's disease (AD) and vascular dementia (VaD) pathologies making the largest contributions. Yet, most genome-wide association studies (GWAS) focus on AD. METHODS: We conducted a GWAS of all-cause dementia (ACD) and examined the genetic overlap with VaD. Our dataset includes 800,597 individuals, with 46,902 and 8702 cases of ACD and VaD, respectively. Known AD loci for ACD and VaD were replicated. Bioinformatic analyses prioritized genes that are likely functionally relevant and shared with closely related traits and risk factors. RESULTS: For ACD, novel loci identified were associated with energy transport (SEMA4D), neuronal excitability (ANO3), amyloid deposition in the brain (RBFOX1), and magnetic resonance imaging markers of small vessel disease (SVD; HBEGF). Novel VaD loci were associated with hypertension, diabetes, and neuron maintenance (SPRY2, FOXA2, AJAP1, and PSMA3). DISCUSSION: Our study identified genetic risks underlying ACD, demonstrating overlap with neurodegenerative processes, vascular risk factors, and cerebral SVD. HIGHLIGHTS: We conducted the largest genome-wide association study of all-cause dementia (ACD) and vascular dementia (VaD). Known genetic variants associated with AD were replicated for ACD and VaD. Functional analyses identified novel loci for ACD and VaD. Genetic risks of ACD overlapped with neurodegeneration, vascular risk factors, and cerebral small vessel disease.

See more in PubMed

Román G. Vascular dementia: a historical background. Int Psychogeriatr. 2003;15(suppl 1):11‐13. PubMed

Dichgans M, Leys D. Vascular cognitive impairment. Circ Res. 2017;120(3):573‐591. PubMed

Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42(9):2672‐2713. PubMed PMC

Rajeev V, Fann DY, Dinh QN, et al. Pathophysiology of blood brain barrier dysfunction during chronic cerebral hypoperfusion in vascular cognitive impairment. Theranostics. 2022;12(4):1639‐1658. PubMed PMC

Sargurupremraj M, Suzuki H, Jian X, et al. Cerebral small vessel disease genomics and its implications across the lifespan. Nat Commun. 2020;11(1):6285. PubMed PMC

Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community‐dwelling older persons. Neurology. 2007;69(24):2197‐2204. PubMed

James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012;307(17):1798‐1800. PubMed PMC

Mönkäre S, Kuuluvainen L, Schleutker J, et al. Genetic analysis reveals novel variants for vascular cognitive impairment. Acta Neurol Scand. 2022;146(1):42‐50. PubMed PMC

Biffi A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol. 2011;7(1):1‐9. PubMed PMC

Markus HS, Schmidt R. Genetics of vascular cognitive impairment. Stroke. 2019;50(3):765‐772. PubMed PMC

Malik R, Chauhan G, Traylor M, et al. Multiancestry genome‐wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524‐537. PubMed PMC

Alber J, Alladi S, Bae HJ, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities. Alzheimers Dement. 2019;5:107‐117. PubMed PMC

Guerreiro R, Gibbons E, Tábuas‐Pereira M, Kun‐Rodrigues C, Santo GC, Bras J. Genetic architecture of common non‐Alzheimer's disease dementias. Neurobiol Dis. 2020;142:104946. PubMed PMC

Schrijvers EM, Schurmann B, Koudstaal PJ, et al. Genome‐wide association study of vascular dementia. Stroke. 2012;43(2):315‐319. PubMed

Kim Y, Kong M, Lee C. Association of intronic sequence variant in the gene encoding spleen tyrosine kinase with susceptibility to vascular dementia. World J Biol Psychiatry. 2013;14(3):220‐226. PubMed

Moreno‐Grau S, de Rojas I, Hernández I, et al. Genome‐wide association analysis of dementia and its clinical endophenotypes reveal novel loci associated with Alzheimer's disease and three causality networks: the GR@ACE project. Alzheimers Dement. 2019;15(10):1333‐1347. PubMed

Ikram MA, Bersano A, Manso‐Calderón R, et al. Genetics of vascular dementia – review from the ICVD working group. BMC Medicine. 2017;15(1):48. PubMed PMC

Marioni RE, Harris SE, Zhang Q, et al. GWAS on family history of Alzheimer's disease. Transl Psychiatry. 2018;8(1):99. PubMed PMC

Ghosh A, Hartge P, Kraft P, et al. Leveraging family history in population‐based case‐control association studies. Genet Epidemiol. 2014;38(2):114‐122. PubMed PMC

McCarthy S, Das S, Kretzschmar W, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016;48(10):1279‐1283. PubMed PMC

Loh P‐R, Tucker G, Bulik‐Sullivan BK, et al. Efficient Bayesian mixed‐model analysis increases association power in large cohorts. Nat Genet. 2015;47(3):284‐290. PubMed PMC

Winkler TW, Day FR, Croteau‐Chonka DC, et al. Quality control and conduct of genome‐wide association meta‐analyses. Nat Protoc. 2014;9(5):1192‐1212. PubMed PMC

Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta‐analysis of genomewide association scans. Bioinformatics. 2010;26:2190‐2191. PubMed PMC

Mägi R, Horikoshi M, Sofer T, et al. Trans‐ethnic meta‐regression of genome‐wide association studies accounting for ancestry increases power for discovery and improves fine‐mapping resolution. Hum Mol Genet. 2017;26(18):3639‐3650. PubMed PMC

de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene‐set analysis of GWAS data. PLoS Comput Biol. 2015;11(4):e1004219. PubMed PMC

Buniello A, MacArthur JAL, Cerezo M, et al. The NHGRI‐EBI GWAS Catalog of published genome‐wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47(D1):D1005‐D1012. PubMed PMC

Evangelou E, Warren HR, Mosen‐Ansorena D, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50(10):1412‐1425. PubMed PMC

Bulik‐Sullivan B, Finucane KH, Anttila V, et al. An atlas of genetic correlations across human diseases and traits. Nat Genet. 2015;47(11):1236‐1241. PubMed PMC

Lu Q, Li B, Ou D, et al. A Powerful approach to estimating annotation‐stratified genetic covariance via GWAS summary statistics. Am Hum Genet. 2017;101(6):939‐964. PubMed PMC

Mounier N, Kutalik Z. Bias correction for inverse variance weighting Mendelian randomization. Genet Epidemiol. 2023;47(4):314‐331. PubMed

Shi H, Mancuso N, Spendlove S, Pasaniuc B. Local genetic correlation gives insights into the shared genetic architecture of complex traits. Am J Hum Genet. 2017;101(5):737‐751. PubMed PMC

Pickrell JK, Berisa T, Liu JZ, Segurel L, Tung JY, Hinds DA. Detection and interpretation of shared genetic influences on 42 human traits. Nat Genet. 2016;48(7):709‐717. PubMed PMC

Stephens M. False discovery rates: a new deal. Biostatistics. 2017;18(2):275‐294. PubMed PMC

Turley P, Walters RK, Maghzian O, et al. Multi‐trait analysis of genome‐wide association summary statistics using MTAG. Nat Genet. 2018;50(2):229‐237. PubMed PMC

Gusev A, Ko A, Shi H, et al. Integrative approaches for large‐scale transcriptome‐wide association studies. Nat Genet. 2016;48(3):245‐252. PubMed PMC

Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10(5):e1004383. PubMed PMC

Ward LD, Kellis M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 2012;40(Database issue):D930‐D934. PubMed PMC

Jansen IE, Savage JE, Watanabe K, et al. Genome‐wide meta‐analysis identifies new loci and functional pathways influencing Alzheimer's disease risk. Nat Genet. 2019;51(3):404‐413. PubMed PMC

Mishra A, Malik R, Hachiya T, et al. Stroke genetics informs drug discovery and risk prediction across ancestries. Nature. 2022;611(7934):115‐123. PubMed PMC

Peyrot WJ, Price AL. Identifying loci with different allele frequencies among cases of eight psychiatric disorders using CC‐GWAS. Nat Genet. 2021;53(4):445‐454. PubMed PMC

Mossink B, Negwer M, Schubert D, Kasri NN. The emerging role of chromatin remodelers in neurodevelopmental disorders: a developmental perspective. Cell Mol Life Sci. 2021;78(6):2517‐2563. PubMed PMC

Bearce EA, Irons ZH, Craig SB, et al. Daw1 regulates the timely onset of cilia motility during development. Development. 2022;149(12):dev200017. PubMed PMC

Chung MS, Langouët M, Chamberlain SJ, Carmichael GG. Prader‐Willi syndrome: reflections on seminal studies and future therapies. Open Biology. 2020;10(9):200195. PubMed PMC

Zuniga G, Levy S, Ramirez P, et al. Tau‐induced deficits in nonsense‐mediated mRNA decay contribute to neurodegeneration. Alzheimers Dement. 2022;19(2):405‐420. PubMed PMC

Bellenguez C, Grenier‐Boley B, Lambert JC. Genetics of Alzheimer's disease: where we are, and where we are going. Curr Opin Neurobiol. 2020;61:40‐48. PubMed

Lange LM, Junker J, Loens S, et al. Genotype‐phenotype relations for isolated dystonia genes: MDSGene Systematic Review. Mov Disord. 2021;36(5):1086‐1103. PubMed

Taniguchi Y, Amazaki M, Furuyama T, et al. Sema4D deficiency results in an increase in the number of oligodendrocytes in healthy and injured mouse brains. J Neurosci Res. 2009;87(13):2833‐2841. PubMed

Feigin A, Evans EE, Fisher TL, et al. Pepinemab antibody blockade of SEMA4D in early Huntington's disease: a randomized, placebo‐controlled, phase 2 trial. Nat Med. 2022;28(10):2183‐2193. PubMed PMC

Kunkle BW, Schmidt M, Klein HU, et al. Novel Alzheimer disease risk loci and pathways in African American individuals using the African genome resources panel: a meta‐analysis. JAMA Neurol. 2021;78(1):102‐113. PubMed PMC

Tomassoni‐Ardori F, Fulgenzi G, Becker J, et al. Rbfox1 up‐regulation impairs BDNF‐dependent hippocampal LTP by dysregulating TrkB isoform expression levels. eLife. 2019;8:e49673. PubMed PMC

Gaussoin SA, Pajewski NM, Chelune G, et al. Effect of intensive blood pressure control on subtypes of mild cognitive impairment and risk of progression from SPRINT study. J Am Geriatr Soc. 2022;70(5):1384‐1393. PubMed PMC

Dabertrand F, Kroigaard C, Bonev AD, et al. Potassium channelopathy‐like defect underlies early‐stage cerebrovascular dysfunction in a genetic model of small vessel disease. Proc Natl Acad Sci USA. 2015;112(7):E796‐E805. PubMed PMC

Kim S, Subramanian V, Abdel‐Latif A, Lee S. Role of heparin‐binding epidermal growth factor‐like growth factor in oxidative stress‐associated metabolic diseases. Metab Syndr Relat Disord. 2020;18(4):186‐196. PubMed PMC

Liu X, Li L, Liu F, et al. ApoE gene polymorphism and vascular dementia in Chinese population: a meta‐analysis. J Neural Transm. 2012;119(3):387‐394. PubMed

Wisniewski T, Drummond E. APOE‐amyloid interaction: therapeutic targets. Neurobiol Dis. 2020;138:104784. PubMed PMC

Serrano‐Pozo A, Das S, Hyman BT. APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches. Lancet Neurol. 2021;20(1):68‐80. PubMed PMC

Duong MT, Nasrallah IM, Wolk DA, Chang CCY, Chang TY. Cholesterol, atherosclerosis, and APOE in vascular contributions to cognitive impairment and dementia (VCID): potential mechanisms and therapy. Front Aging Neurosci. 2021;13:647990. PubMed PMC

Schilling S, DeStefano AL, Sachdev PS, et al. APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta‐analysis. Neurology. 2013;81(3):292‐300. PubMed PMC

Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J Mol Med. 2016;94(7):739‐746. PubMed PMC

Carulli D, de Winter F, Verhaagen J. Semaphorins in adult nervous system plasticity and disease. Front Synaptic Neurosci. 2021;13:672891. PubMed PMC

Klimaschewski L, Sueiro BP, Millan LM. siRNA mediated down‐regulation of Sprouty2/4 diminishes ischemic brain injury. Neurosci Lett. 2016;612:48‐51. PubMed

Gross I, Armant O, Benosman S, et al. Sprouty2 inhibits BDNF‐induced signaling and modulates neuronal differentiation and survival. Cell Death Differ. 2007;14(10):1802‐1812. PubMed

Shaik NF, Regan RF, Naik UP. Platelets as drivers of ischemia/reperfusion injury after stroke. Blood Adv. 2021;5(5):1576‐1584. PubMed PMC

Yan H, Kanki H, Matsumura S, et al. MiRNA‐132/212 regulates tight junction stabilization in blood‐brain barrier after stroke. Cell Death Discov. 2021;7(1):380. PubMed PMC

Alkallas R, Fish L, Goodarzi H, Najafabadi HS. Inference of RNA decay rate from transcriptional profiling highlights the regulatory programs of Alzheimer's disease. Nat Commun. 2017;8(1):909. PubMed PMC

Weinstein G, Beiser AS, Choi SH, et al. Serum brain‐derived neurotrophic factor and the risk for dementia: the Framingham Heart Study. JAMA Neurol. 2014;71(1):55‐61. PubMed PMC

Mattiola I, Mantovani A, Locati M. The tetraspan MS4A family in homeostasis, immunity, and disease. Trends Immunol. 2021;42(9):764‐781. PubMed

Liu H, Liu M, Li W, et al. Association of ACE I/D gene polymorphism with vascular dementia: a meta‐analysis. J Geriatr Psychiatry Neurol. 2009;22(1):10‐22. PubMed

Koronyo‐Hamaoui M, Sheyn J, Hayden EY, et al. Peripherally derived angiotensin converting enzyme‐enhanced macrophages alleviate Alzheimer‐related disease. Brain. 2020;143(1):336‐358. PubMed PMC

Zhang H, Mo X, Wang A, et al. Association of DNA methylation in blood pressure‐related genes with ischemic stroke risk and prognosis. Front Cardiovasc Med. 2022;9:796245. PubMed PMC

Davis CA, Haberland M, Arnold MA, et al. PRISM/PRDM6, a transcriptional repressor that promotes the proliferative gene program in smooth muscle cells. Mol Cell Biol. 2006;26(7):2626‐2636. PubMed PMC

Kjeldsen EW, Nordestgaard LT, Frikke‐Schmidt R. HDL cholesterol and non‐cardiovascular disease: a narrative review. Int J Mol Sci. 2021;22(9):4547. PubMed PMC

Van Lenten BJ, Hama SY, de Beer FC, et al. Anti‐inflammatory HDL becomes pro‐inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest. 1995;96(6):2758‐2767. PubMed PMC

Luo J, Thomassen JQ, Bellenguez C, et al. Genetic associations between modifiable risk factors and Alzheimer disease. JAMA Netw Open. 2023;6(5):e2313734. PubMed PMC

Skrobot OA, Black SE, Chen C, et al. Progress toward standardized diagnosis of vascular cognitive impairment: guidelines from the Vascular Impairment of Cognition Classification Consensus Study. Alzheimers Dement. 2018;14(3):280‐292. PubMed